Literature DB >> 10932846

Strategies to optimize the impact of needle exchange programs.

J D Rich1, L L Strong, M Mehrotra, G Macalino.   

Abstract

In the United States today, half of all new HIV infections are injection drug use-associated, many of which are a result of the reuse and sharing of contaminated syringes. Thus, providing access to sterile syringes for injection drug users is an important part of preventing HIV transmission. Needle exchange programs (NEPs) have been established as one successful approach to providing sterile injection equipment. The medical literature shows that these programs are effective in decreasing both syringe sharing and HIV incidence in injection drug users. In addition, many NEPs are also beneficial because they provide other injection drug use-relevant services. There are several strategies that can be adopted in order to optimize the impact of needle exchange programs, at both the community and national levels. These include establishing NEPs in communities that need them, expanding and improving those that already exist, and implementing such programs on a larger national scale with the provision of federal funds.

Entities:  

Mesh:

Year:  2000        PMID: 10932846

Source DB:  PubMed          Journal:  AIDS Read        ISSN: 1053-0894


  4 in total

1.  Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.

Authors:  Nickolas Zaller; Alexandra Jeronimo; Jeffrey Bratberg; Patricia Case; Josiah D Rich
Journal:  J Urban Health       Date:  2010-12       Impact factor: 3.671

2.  Syringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island.

Authors:  Nickolas D Zaller; Michael A Yokell; Sandeep M Nayak; Jeannia J Fu; Alexander R Bazazi; Josiah D Rich
Journal:  J Urban Health       Date:  2012-08       Impact factor: 3.671

3.  Adverse event associated with a change in nonprescription syringe sale policy.

Authors:  Nickolas D Zaller; Michael A Yokell; Alexandra Jeronimo; Jeffrey P Bratberg; Patricia Case; Josiah D Rich
Journal:  J Am Pharm Assoc (2003)       Date:  2010 Sep-Oct

4.  A syringe prescription program to prevent infectious disease and improve health of injection drug users.

Authors:  Josiah D Rich; Michelle McKenzie; Grace E Macalino; Lynn E Taylor; Stephanie Sanford-Colby; Francis Wolf; Susan McNamara; Meenakshi Mehrotra; Michael D Stein
Journal:  J Urban Health       Date:  2004-03       Impact factor: 3.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.